Volume 15 Supplement 1

Proceedings of the International Cancer Imaging Society (ICIS) 15th Annual Teaching Course

Open Access

Spots and dots in the bones

  • Philippa Tyler1, 2
Cancer Imaging201515(Suppl 1):O4

https://doi.org/10.1186/1470-7330-15-S1-O4

Published: 2 October 2015

Cancer imaging is frequently at the cutting edge of new imaging techniques which are often rapidly incorporated into routine use.

Skeletal metastatic disease is a frequent complication of neoplastic conditions, and results in specific challenges to the general radiologist and specialist oncological radiologist alike.

Non-neoplastic conditions and normal variants may simulate skeletal metastases, and the radiologist must recognise such cases and avoid over-investigation and unnecessary treatment.

This lecture will briefly review standard imaging techniques and demonstrate normal appearances, normal variants and non-neoplastic lesions that mimic primary and secondary skeletal malignancy, and will then review a spectrum of malignancy-associated bone lesions with the use of standard and more specialised imaging techniques, including PET MRI, PET CT and diffusion weighted imaging,.

Expected post treatment imaging findings, and treatment-associated complications will also be discussed.

Authors’ Affiliations

(1)
The Royal National Orthopaedic Hospital
(2)
Institute of Orthopaedics, University College London

References

  1. Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM: MR imaging and PET/CT in diagnosisand management of multiple myeloma. Radiographics. 2015, 35 (2): 438-54. 10.1148/rg.352140112. doi: 10.1148/rg.352140112. PMID: 25763728PubMedView ArticleGoogle Scholar
  2. Subhawong TK, Wilky BA: Value added :functional MR imagingin management of bone and soft tissue sarcomas. Curr Opin Oncol. 2015, 27 (4): 323-31. 10.1097/CCO.0000000000000199. doi: 10.1097/CCO.0000000000000199. PMID:26049272PubMedView ArticleGoogle Scholar
  3. Del Vescovo R, Frauenfelder G, Giurazza F, Piccolo CL, Cazzato RL, Grasso RF, Schena E, Zobel BB: Role ofwhole-body diffusion-weighted MRI in detecting bone metastasis. Radiol Med. 2014, 119 (10): 758-66. 10.1007/s11547-014-0395-y. doi: 10.1007/s11547-014-0395-y. Epub 2014 Mar 18PubMedView ArticleGoogle Scholar
  4. Alexiou E, Georgoulias P, Valotassiou V, Georgiou E, Fezoulidis I, Vlychou M: Multifocal septic osteomyelitis mimicking skeletalmetastatic diseasein a patient with prostate cancer. Hell J Nucl Med. 2015, 18 (1): 77-8. doi: 10.1967/s002449910168PubMedGoogle Scholar
  5. Beiderwellen K, Huebner M, Heusch P, Grueneisen J, Ruhlmann V, Nensa F, Kuehl H, Umutlu L, Rosenbaum-Krumme S, Lauenstein TC: Whole-body[18F]FDG PET/MRI vs. PET/CT in the assessment of bonelesions in oncological patients: initial results. Eur Radiol. 2014, 24 (8): 2023-30. 10.1007/s00330-014-3229-3. doi: 10.1007/s00330-014-3229-3. Epub 2014 Jun 8PubMedView ArticleGoogle Scholar

Copyright

© Tyler 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement